Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Hims & Hers Health, Inc. (HIMS) shares rallied 27.7% in the last trading session to close at $59.18. This move can be attributable to notable volume with a higher number of shares being traded than in ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The 21-year-old centre from Dartmouth College has pro-ready habits and size worth a flier of a cheap contract from a team ...